Latest

• Antimicrobial drug consumption in the Russian Federation (2008–2022): pharmacoepidemiological study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(4):395-400

• A systematic review and meta-analysis of the safety of anti-interleukin therapy in COVID-19

  Clinical Microbiology and Antimicrobial Chemotherapy. 2022; 24(2):93-107

• Problems of assessing economic effectiveness of antimicrobial agents: an experience of the Russian Federation

  Clinical Microbiology and Antimicrobial Chemotherapy. 2022; 24(1):23-29

• Integrated analysis of antibiotic consumption in the hospital segment of Saint-Petersburg in 2014–2018

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(3):238-244

• Burden of resistant infections caused by S. aureus, E. coli, K. pneumoniae in Russian Federation

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(4):310-318

• Calculation of the optimal structure of antibiotic consumption in a hospital based on the predicted antimicrobial resistance in the treatment of uncomplicated acute pyelonephritis

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(3):223-231

• Analysis of effectiveness criteria in pharmacoeconomic studies of antimicrobial agents proposed for inclusion in the Russian essential drug list in the 2014 -2016

  Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(3):260-264